Oruka Therapeutics, Inc. Financing Cash Flow
Oruka Therapeutics, Inc. (ORKA) reported Financing Cash Flow of $703.64 million for the 6-month period ending 2026-06-30, per its 10-Q filed 2026-08-10.
Financial Statements › Cash Flow › Financing Activities
us-gaap:NetCashProvidedByUsedInFinancingActivities · last filed 2026-08-10
- Oruka Therapeutics, Inc. net cash provided by (used in) financing activities for the quarter ending 2026-06-30 was $663.04M.
- Oruka Therapeutics, Inc. net cash provided by (used in) financing activities for the quarter ending 2026-03-31 was $40.60M.
- Oruka Therapeutics, Inc. net cash provided by (used in) financing activities for the quarter ending 2025-12-31 was $298.00K.
- Oruka Therapeutics, Inc. net cash provided by (used in) financing activities for the quarter ending 2025-09-30 was $169.91M.
- Oruka Therapeutics, Inc. net cash provided by (used in) financing activities for fiscal 2025 was $170.31M.
- Oruka Therapeutics, Inc. net cash provided by (used in) financing activities for fiscal 2023 was $0.00.
- Oruka Therapeutics, Inc. net cash provided by (used in) financing activities for fiscal 2022 was $0.00, a 100.00% decline from fiscal 2021.
- Oruka Therapeutics, Inc. net cash provided by (used in) financing activities for fiscal 2021 was $23.09M, a 52.34% decline from fiscal 2020.
| Period end | Net Cash Provided by (Used in) Financing Activities 2 month | Net Cash Provided by (Used in) Financing Activities 3 month | Net Cash Provided by (Used in) Financing Activities 5 month | Net Cash Provided by (Used in) Financing Activities 6 month | Net Cash Provided by (Used in) Financing Activities 8 month | Net Cash Provided by (Used in) Financing Activities 9 month | Net Cash Provided by (Used in) Financing Activities 11 month | Net Cash Provided by (Used in) Financing Activities 12 month | Net Cash Provided by (Used in) Financing Activities 114 month | Net Cash Provided by (Used in) Financing Activities 117 month | Net Cash Provided by (Used in) Financing Activities 120 month | Net Cash Provided by (Used in) Financing Activities 123 month | Net Cash Provided by (Used in) Financing Activities 126 month | Net Cash Provided by (Used in) Financing Activities 129 month | Net Cash Provided by (Used in) Financing Activities 132 month | Net Cash Provided by (Used in) Financing Activities 135 month | Net Cash Provided by (Used in) Financing Activities 138 month | Net Cash Provided by (Used in) Financing Activities 141 month | Net Cash Provided by (Used in) Financing Activities 144 month |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2026-06-30 | $663.04M derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-10 | $703.64M 10-Q · filed 2026-08-10 | $703.94M derived: sum of 3 quarters · filed 2026-08-10 | $873.85M derived: sum of 4 quarters · filed 2026-08-10 | |||||||||||||||
| 2026-03-31 | $40.60M 10-Q · filed 2026-05-13 | $40.90M derived: sum of 2 quarters · filed 2026-05-13 | $210.81M derived: sum of 3 quarters · filed 2026-05-13 | ||||||||||||||||
| 2025-12-31 | $298.00K derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-12 | $170.21M derived: sum of 2 quarters · filed 2026-03-12 | $170.31M 10-K · filed 2026-03-12 | ||||||||||||||||
| 2025-09-30 | $169.91M derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-12 | $170.02M 10-Q · filed 2025-11-12 | |||||||||||||||||
| 2025-06-30 | $109.00K 10-Q · filed 2026-08-10 | ||||||||||||||||||
| 2024-12-31 | $449.54M 10-K · filed 2026-03-12 | ||||||||||||||||||
| 2024-09-30 | $450.06M 10-Q · filed 2025-11-12 | ||||||||||||||||||
| 2024-06-30 | $14.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2024-08-01 | $26.32M 10-Q · filed 2025-08-11 | $14.00K 10-Q · filed 2024-08-01 | ||||||||||||||||
| 2024-03-31 | $27.91M 10-Q · filed 2025-05-14 | $0.00 10-Q · filed 2024-04-25 | |||||||||||||||||
| 2023-12-31 | $0.00 10-K · filed 2024-02-01 | ||||||||||||||||||
| 2023-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2024-08-01 | $0.00 10-Q · filed 2024-08-01 | |||||||||||||||||
| 2023-03-31 | $0.00 10-Q · filed 2024-04-25 | ||||||||||||||||||
| 2022-12-31 | $0.00 10-K · filed 2024-02-01 | ||||||||||||||||||
| 2021-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2023-02-24 | $0.00 derived: sum of 2 quarters · filed 2023-02-24 | $0.00 derived: sum of 3 quarters · filed 2023-02-24 | $23.09M 10-K · filed 2023-02-24 | |||||||||||||||
| 2021-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2022-10-28 | $0.00 derived: sum of 2 quarters · filed 2022-10-28 | $23.09M 10-Q · filed 2022-10-28 | $24.08M derived: sum of 4 quarters · filed 2022-10-28 | |||||||||||||||
| 2021-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2022-08-02 | $23.09M 10-Q · filed 2022-08-02 | $24.08M derived: sum of 3 quarters · filed 2022-08-02 | $66.13M derived: sum of 4 quarters · filed 2022-08-02 | |||||||||||||||
| 2021-03-31 | $23.09M 10-Q · filed 2022-05-02 | $24.08M derived: sum of 2 quarters · filed 2022-05-02 | $66.13M derived: sum of 3 quarters · filed 2022-05-02 | ||||||||||||||||
| 2020-12-31 | $984.00K derived: 10-K 12 month − 10-Q 9 month · filed 2022-03-14 | $43.04M derived: sum of 2 quarters · filed 2022-03-14 | $48.45M 10-K · filed 2022-03-14 | ||||||||||||||||
| 2020-09-30 | $42.06M derived: 10-Q 9 month − 10-Q 6 month · filed 2021-11-02 | $47.47M 10-Q · filed 2021-11-02 | |||||||||||||||||
| 2020-06-30 | $5.41M 10-Q · filed 2021-08-04 | ||||||||||||||||||
| 2019-12-31 | -$122.00K derived: 10-K 12 month − 10-Q 9 month · filed 2021-03-18 | $446.00K derived: sum of 2 quarters · filed 2021-03-18 | $3.60M derived: sum of 3 quarters · filed 2021-03-18 | $6.56M 10-K · filed 2021-03-18 | |||||||||||||||
| 2019-09-30 | $568.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2020-11-02 | $3.72M derived: sum of 2 quarters · filed 2020-11-02 | $6.68M 10-Q · filed 2020-11-02 | $6.58M derived: sum of 4 quarters · filed 2020-11-02 | |||||||||||||||
| 2019-06-30 | $3.15M derived: 10-Q 6 month − 10-Q 3 month · filed 2020-08-05 | $6.11M 10-Q · filed 2020-08-05 | $6.01M derived: sum of 3 quarters · filed 2020-08-05 | $6.01M derived: sum of 4 quarters · filed 2020-08-05 | |||||||||||||||
| 2019-03-31 | $2.96M 10-Q · filed 2020-05-06 | $2.86M derived: sum of 2 quarters · filed 2020-05-06 | $2.86M derived: sum of 3 quarters · filed 2020-05-06 | $2.65M derived: sum of 4 quarters · filed 2020-05-06 | |||||||||||||||
| 2018-12-31 | -$105.00K derived: 10-K 12 month − 10-Q 9 month · filed 2020-02-18 | -$105.00K derived: sum of 2 quarters · filed 2020-02-18 | -$312.00K derived: sum of 3 quarters · filed 2020-02-18 | $3.10M 10-K · filed 2020-02-18 | |||||||||||||||
| 2018-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2019-11-06 | -$207.00K derived: sum of 2 quarters · filed 2019-11-06 | $3.21M 10-Q · filed 2019-11-06 | $3.22M derived: sum of 4 quarters · filed 2019-11-06 | |||||||||||||||
| 2018-06-30 | -$207.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2019-08-01 | $3.21M 10-Q · filed 2019-08-01 | $3.22M derived: sum of 3 quarters · filed 2019-08-01 | $7.16M derived: sum of 4 quarters · filed 2019-08-01 | |||||||||||||||
| 2018-03-31 | $3.42M 10-Q · filed 2019-05-08 | $3.42M derived: sum of 2 quarters · filed 2019-05-08 | $7.37M derived: sum of 3 quarters · filed 2019-05-08 | ||||||||||||||||
| 2017-12-31 | $7.00K derived: 10-K 12 month − 10-Q 9 month · filed 2019-02-27 | $3.95M derived: sum of 2 quarters · filed 2019-02-27 | $5.85M 10-K · filed 2019-02-27 | ||||||||||||||||
| 2017-09-30 | $3.95M derived: 10-Q 9 month − 10-Q 6 month · filed 2018-11-14 | $5.84M 10-Q · filed 2018-11-14 | |||||||||||||||||
| 2017-06-30 | $1.89M 10-Q · filed 2018-08-09 | ||||||||||||||||||
| 2013-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2014-03-20 | -$55.00K derived: sum of 2 quarters · filed 2014-03-20 | $17.77M derived: sum of 3 quarters · filed 2014-03-20 | $19.16M 10-K · filed 2014-03-20 | $74.44M 10-K · filed 2014-03-20 | ||||||||||||||
| 2013-09-30 | -$55.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2013-11-13 | $17.77M derived: sum of 2 quarters · filed 2013-11-13 | $19.16M 10-Q · filed 2013-11-13 | $19.66M derived: sum of 4 quarters · filed 2014-03-20 | $74.44M 10-Q · filed 2013-11-13 | ||||||||||||||
| 2013-06-30 | $17.82M derived: 10-Q 6 month − 10-Q 3 month · filed 2013-08-13 | $19.21M 10-Q · filed 2013-08-13 | $19.72M derived: sum of 3 quarters · filed 2014-03-20 | $20.39M derived: sum of 4 quarters · filed 2014-03-20 | $74.50M 10-Q · filed 2013-08-13 | ||||||||||||||
| 2013-03-31 | $1.39M 10-Q · filed 2013-05-13 | $1.90M derived: sum of 2 quarters · filed 2014-03-20 | $2.57M derived: sum of 3 quarters · filed 2014-03-20 | $2.50M derived: sum of 4 quarters · filed 2014-03-20 | $56.68M 10-Q · filed 2013-05-13 | ||||||||||||||
| 2012-12-31 | $508.00K derived: 10-K 12 month − 10-Q 9 month · filed 2014-03-20 | $1.18M derived: sum of 2 quarters · filed 2014-03-20 | $1.11M derived: sum of 3 quarters · filed 2014-03-20 | $1.05M 10-K · filed 2014-03-20 | $55.29M 10-K · filed 2013-03-21 | ||||||||||||||
| 2012-09-30 | $674.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2013-11-13 | $607.00K derived: sum of 2 quarters · filed 2013-11-13 | $547.00K 10-Q · filed 2013-11-13 | $1.97M derived: sum of 4 quarters · filed 2013-11-13 | $54.78M 10-Q · filed 2012-11-13 | ||||||||||||||
| 2012-06-30 | -$67.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2013-08-13 | -$127.00K 10-Q · filed 2013-08-13 | $1.30M derived: sum of 3 quarters · filed 2013-08-13 | $1.26M derived: sum of 4 quarters · filed 2013-08-13 | $54.10M 10-Q · filed 2012-08-13 | ||||||||||||||
| 2012-03-31 | -$60.00K 10-Q · filed 2013-05-13 | $1.37M derived: sum of 2 quarters · filed 2013-05-13 | $1.33M derived: sum of 3 quarters · filed 2013-05-13 | $54.17M 10-Q · filed 2012-05-14 | |||||||||||||||
| 2011-12-31 | $1.43M derived: 10-K 12 month − 10-Q 9 month · filed 2013-03-21 | $1.39M derived: sum of 2 quarters · filed 2013-03-21 | $3.87M 10-K · filed 2013-03-21 | $54.23M 10-K · filed 2012-03-27 | |||||||||||||||
| 2011-09-30 | -$40.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2012-11-13 | $2.44M 10-Q · filed 2012-11-13 | $52.81M 10-Q · filed 2011-11-14 | ||||||||||||||||
| 2011-06-30 | $2.48M 10-Q · filed 2012-08-13 | $52.85M 10-Q · filed 2011-08-15 | |||||||||||||||||
| 2010-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2012-03-27 | $1.00K derived: sum of 2 quarters · filed 2012-03-27 | $7.32M 10-K · filed 2012-03-27 | ||||||||||||||||
| 2010-09-30 | $1.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2011-11-14 | $7.32M 10-Q · filed 2011-11-14 | |||||||||||||||||
| 2010-06-30 | $7.32M 10-Q · filed 2011-08-15 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Travere Therapeutics, Inc. (TVTX) | United States | $5.712B | -123.10 |
| Mirum Pharmaceuticals, Inc. (MIRM) | United States | $5.798B | -8.81 |
| Cogent Biosciences, Inc. (COGT) | United States | $5.450B | -17.61 |
| Gossamer Bio, Inc. (GOSS) | United States | $5.355B | -0.65 |
| PTC THERAPEUTICS, INC. (PTCT) | United States | $5.199B | -177.07 |
| Dianthus Therapeutics, Inc. /DE/ (DNTH) | United States | $5.082B | -27.79 |
| Erasca, Inc. (ERAS) | United States | $5.073B | -19.96 |
| Amneal Pharmaceuticals, Inc. (AMRX) | $6.326B | 25.62 | |
| Liquidia Corp (LQDA) | United States | $6.347B | 51.23 |
| Veradermics, Inc (MANE) | United States | $4.839B |